BR0209619A - Uso de derivados de ciclosporina de posição 3 para crescimento capilar - Google Patents

Uso de derivados de ciclosporina de posição 3 para crescimento capilar

Info

Publication number
BR0209619A
BR0209619A BR0209619-6A BR0209619A BR0209619A BR 0209619 A BR0209619 A BR 0209619A BR 0209619 A BR0209619 A BR 0209619A BR 0209619 A BR0209619 A BR 0209619A
Authority
BR
Brazil
Prior art keywords
hair growth
cyclosporine derivatives
active ingredient
cyclosporin
promoting agent
Prior art date
Application number
BR0209619-6A
Other languages
English (en)
Other versions
BRPI0209619B1 (pt
BRPI0209619B8 (pt
Inventor
Sang-Nyun Kim
Ho-Jeong Ahn
Chang-Woo Lee
Min-Ho Lee
Jung-Hun Kim
Jong-Ii Kim
Seung-Jin Kim
Ho-Song Cho
Heon-Sik Lee
Hyung-Jin Kim
Original Assignee
Lg Household & Health Care Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Household & Health Care Ltd filed Critical Lg Household & Health Care Ltd
Publication of BR0209619A publication Critical patent/BR0209619A/pt
Publication of BRPI0209619B1 publication Critical patent/BRPI0209619B1/pt
Publication of BRPI0209619B8 publication Critical patent/BRPI0209619B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"USO DE DERIVADOS DE CICLOSPORINA DE POSIçãO 3 PARA CRESCIMENTO CAPILAR". A invenção presente divulga um agente promotor de crescimento capilar compreendendo um derivado de ciclosporina como ingrediente ativo, e mais particularmente, um agente promotor de crescimento capilar compreendendo um derivado de ciclosporina A substituido na posição 3 como ingrediente ativo.
BRPI0209619A 2001-05-11 2002-05-11 agente promotor de crescimento capilar BRPI0209619B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2001-0025682A KR100465012B1 (ko) 2001-05-11 2001-05-11 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
PCT/KR2002/000879 WO2002092032A1 (en) 2001-05-11 2002-05-11 Use of 3-position cyclosporin derivatives for hair growth

Publications (3)

Publication Number Publication Date
BR0209619A true BR0209619A (pt) 2004-03-30
BRPI0209619B1 BRPI0209619B1 (pt) 2015-05-19
BRPI0209619B8 BRPI0209619B8 (pt) 2021-05-25

Family

ID=19709334

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209619A BRPI0209619B8 (pt) 2001-05-11 2002-05-11 agente promotor de crescimento capilar

Country Status (17)

Country Link
US (2) US6790830B2 (pt)
EP (1) EP1387660B1 (pt)
JP (1) JP4214181B2 (pt)
KR (1) KR100465012B1 (pt)
CN (1) CN1248671C (pt)
AT (1) ATE473730T1 (pt)
AU (1) AU2002258271B2 (pt)
BR (1) BRPI0209619B8 (pt)
CA (1) CA2446971C (pt)
DE (1) DE60237003D1 (pt)
ES (1) ES2348225T3 (pt)
MX (1) MXPA03010027A (pt)
PL (1) PL208536B1 (pt)
RU (1) RU2291682C2 (pt)
TR (1) TR200301931T2 (pt)
WO (1) WO2002092032A1 (pt)
ZA (1) ZA200308532B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020039528A (ko) * 2000-11-22 2002-05-27 조명재 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제
KR100865211B1 (ko) * 2001-10-26 2008-10-23 주식회사 엘지생활건강 비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
US20090041442A1 (en) * 2006-03-06 2009-02-12 Rouse Jr Martin D Thermal Vaporizer Apparatus
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2010138422A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
WO2010146622A1 (ja) 2009-06-15 2010-12-23 花王株式会社 Nfatシグナル阻害剤及びカルシニューリン阻害剤
DK2651965T3 (en) 2010-12-15 2019-02-18 Contravir Pharmaceuticals Inc CYCLOSPORIN ANALOGUAL MODULES MODIFIED BY AMINO ACID 1 AND 3
RU2479872C1 (ru) * 2012-01-11 2013-04-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ коррекции ишемических нарушений, возникших в результате реперфузионной травмы печени
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders
KR102469342B1 (ko) * 2021-06-14 2022-11-21 주식회사 오리엔트바이오 환형 펩타이드를 포함하는 방출조절형 국소주사용 조성물 및 이의 제조방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243008A (ja) 1984-05-17 1985-12-03 Wakamoto Pharmaceut Co Ltd 発毛養毛剤
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
JPS6219512A (ja) 1985-07-17 1987-01-28 Shiseido Co Ltd 養毛剤
JPS6219513A (ja) 1985-07-17 1987-01-28 Shiseido Co Ltd 養毛剤
CH679119A5 (pt) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5284826A (en) * 1989-07-24 1994-02-08 Sandoz Ltd. 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins
GB9203886D0 (en) * 1992-02-24 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
JPH07316023A (ja) * 1994-05-26 1995-12-05 Shiseido Co Ltd 育毛料
AU722858B2 (en) * 1995-07-17 2000-08-10 Scynexis, Inc. Cyclosporin derivatives having an anti-HIV effect
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
CN1205220C (zh) * 1998-06-12 2005-06-08 斯－凯穆公司 新颖的环孢菌素
FR2780061B1 (fr) * 1998-06-22 2001-09-07 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
EP1161222A1 (en) 1999-03-05 2001-12-12 University Of Texas Southwestern Medical Center Method of treating hair loss using non-immunosuppressive compounds
EP1233738A1 (en) * 1999-11-19 2002-08-28 LG Household & Health Care Ltd. Use of nonimmunosuppressive cyclosporin derivatives for hair growth
US6521595B1 (en) * 1999-11-19 2003-02-18 Lg Chemical, Ltd. Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same
KR100316604B1 (ko) * 1999-11-19 2001-12-12 성재갑 모발 성장 효과를 갖는 비면역억제 사이클로스포린 에이유도체
KR20020039528A (ko) * 2000-11-22 2002-05-27 조명재 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제
KR100360716B1 (ko) * 2000-11-22 2002-11-13 주식회사 엘지생활건강 사이클로스포린 에이 7- 티오아미드 유도체를유효성분으로 하는 모발성장촉진제
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100695610B1 (ko) * 2001-05-15 2007-03-14 주식회사 엘지생활건강 비면역성 발모성분인 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 함유한 두피 및 경피용 제제 조성물
KR100695611B1 (ko) * 2001-05-17 2007-03-14 주식회사 엘지생활건강 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제

Also Published As

Publication number Publication date
JP4214181B2 (ja) 2009-01-28
BRPI0209619B1 (pt) 2015-05-19
RU2003135846A (ru) 2005-03-27
EP1387660B1 (en) 2010-07-14
PL366407A1 (en) 2005-01-24
TR200301931T2 (tr) 2004-09-21
AU2002258271B2 (en) 2006-06-29
US6790830B2 (en) 2004-09-14
EP1387660A1 (en) 2004-02-11
PL208536B1 (pl) 2011-05-31
KR100465012B1 (ko) 2005-01-13
JP2004530685A (ja) 2004-10-07
KR20020086041A (ko) 2002-11-18
ATE473730T1 (de) 2010-07-15
CA2446971A1 (en) 2002-11-21
DE60237003D1 (de) 2010-08-26
BRPI0209619B8 (pt) 2021-05-25
MXPA03010027A (es) 2005-09-08
US20030186857A1 (en) 2003-10-02
US6762164B2 (en) 2004-07-13
ES2348225T3 (es) 2010-12-01
EP1387660A4 (en) 2006-05-17
CN1248671C (zh) 2006-04-05
WO2002092032A1 (en) 2002-11-21
CN1507339A (zh) 2004-06-23
RU2291682C2 (ru) 2007-01-20
US20030207798A1 (en) 2003-11-06
ZA200308532B (en) 2004-07-01
CA2446971C (en) 2011-07-05

Similar Documents

Publication Publication Date Title
HUP0400723A3 (en) Isoxazoline derivatives and herbicide composition comprising the same as active ingredient
EP1178786A4 (en) PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE
BG106030A (en) Pharmaceutical composition
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
AU2001277543A1 (en) Synergistically active mixture which inhibits hair growth
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
BR0209619A (pt) Uso de derivados de ciclosporina de posição 3 para crescimento capilar
PT1089704E (pt) Locao tricologica para aplicacao topica
AU2002302544A1 (en) Active ingredient combinations for hair-dyeing agents
DK1330258T3 (da) Kahalalid F-formulering
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
AU2001286242A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
EP1560558A4 (en) USE OF CYCLOSPORINE DERIVATIVES IN POSITION 3 FOR CAPILLARY GROWTH
AU2001269252A1 (en) Alcohol-free base for aqueous perfume composition, and alcohol-free aqueous perfume composition comprising same
WO2000069425A3 (de) Endoparasitizide synergistische kombination enthaltend cyclischen depsipeptiden und piperazinen
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
HRP20020071B1 (en) Pharmaceutical composition and preparation thereof
BR9917431B1 (pt) derivado de 1-cicloalquilpirazolilbenzoìla, composição, processos para preparar derivados de 1-cicloalquilpirazolilbenzoìla e para preparar composições, método para controlar a vegetação não desejada, e, uso dos derivados de 1-cicloalquilpirazolilbenzoìla.
HUP0402072A3 (en) Glycine derivatives containing 1,3-oxazole or -thiazole ring and drugs containing the same as active ingredient
PT1194158E (pt) Uso da proteina uk 114 para inibir a rejeicao do transplante de orgaos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2258 DE 15/04/2014.

B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 7/06

Ipc: A61K 8/64 (2006.01), A61Q 5/12 (2006.01), A61Q 7/0

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/05/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/05/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2722 DE 07/03/2023 POR TER SIDO INDEVIDA, UMA VEZ QUE A VALIDADE DA PATENTE FOI ALTERADA PARA 20 ANOS CONTADOS DO DEPOSITO, CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 11/05/2022